Understanding how cells control protein breakdown
New Mechanisms and Functions of the Pro/N Degron and Arg/N-Degron Pathways
This research explores how our cells naturally break down proteins, a process vital for health and linked to many diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11118984 on NIH RePORTER |
What this research studies
Our bodies constantly build and break down proteins, and this balance is crucial for staying healthy. This project focuses on a key cellular system, called the ubiquitin-proteasome system, which acts like a recycling plant for proteins. We are learning more about specific pathways within this system, known as N-degron pathways, that mark certain proteins for breakdown. By understanding these fundamental processes, we hope to uncover new insights into how they go wrong in conditions like cancer, neurodegenerative disorders, and immune problems.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to advance our understanding of basic biological processes relevant to many human diseases.
Not a fit: Patients seeking immediate clinical interventions or direct treatment options would not benefit from this basic science research.
Why it matters
Potential benefit: If successful, this work could reveal new targets for developing treatments for a wide range of diseases where protein breakdown is disrupted.
How similar studies have performed: This research builds upon over three decades of successful studies in the field of protein degradation pathways, indicating a well-established and productive area of inquiry.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Varshavsky, Alexander J — California Institute of Technology
- Study coordinator: Varshavsky, Alexander J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.